OLF1R Olaines Kimiski - Farmaceitiska Rupnica

Olainfarm confirmed the compliance with Russian Good Manufacturing Practice (GMP)

Olainfarm confirmed the compliance with Russian Good Manufacturing Practice (GMP)

JSC Olainfarm has received Russian certificate of Good Manufacturing Practice which confirms the company's care for the quality system, including the maintenance of requirements for the production and quality control of medicines, and compliance with the market of Russia. The receiving of the certificate gives the opportunity for the company to fully continue operations in Russia, which is one of Olainfarm's key export markets.

“The company is taking care of the product quality compliance with both international and national standards, including the requirements of the European Union and Russian regulations. Receipt of the certificate allows the company to continue achieving its goals. Special thanks to colleagues who have been working long-term to ensure that the company is meeting the highest standarts,” says Raimonds Terentjevs, Member of the Board of JSC Olainfarm and Director of the Quality Management Department.

“One of the goals and tasks of Olainfarm is to build trust with customers by producing quality products in accordance with the requirements of Good Manufacturing Practices. Investments in the development and modernization of the company, as well as the work of all our team, allow Olainfarm to be among the pharmaceutical companies that received the Russian Good Manufacturing Practice Certificate in October. In 2019, 32% of Olainfarm's products were exported to Russia, in line with quality requirements and a high sense of responsibility for human health and well-being. Receiving of the certificate is especially important because that way, the company has a strategically important position by combining compliance with Russian and European requirements,” emphasized Milana Beļeviča, Member of the Board of JSC Olainfarm.

JSC Olainfarm is equipped with modern technologies and certified in accordance with the requirements of Good Manufacturing Practice of Russia and EU, the Environmental Management Standard ISO 14001:2015, laboratory standard ISO 17025, in separate categories – US inspection standards (FDA), inspection standards of Australia (TGA) and Japan (PMDA). The Russian GMP Certificate is issued for three years.

JSC Olainfarm is one of the largest companies in the Baltic States with more than 45 years of experience in the production of medicines and chemical pharmaceutical products. The basic principle of the company's activity is to produce reliable and efficient products of the highest quality for Latvia and the whole world. Currently, the products of JSC Olainfarm are exported to more than 50 countries and territories of the world, including the Baltic States, Russia, other CIS countries, Europe, North America, Asian countries and Australia.

Additional information:  

Jānis Dubrovskis

Investor Relations Advisor of JSC Olainfarm

Phone:

Email:

EN
02/11/2020

Underlying

Reports on Olaines Kimiski - Farmaceitiska Rupnica

 PRESS RELEASE

Delisting of AS "Olainfarm” shares from the Baltic Main list

Delisting of AS "Olainfarm” shares from the Baltic Main list Delisting of AS "Olainfarm” shares from the Baltic Main list With this AS "Olainfarm” informs, that Nasdaq Riga decided on January 7, 2022 to approve the application of AS "Olainfarm” and to delist its shares (ISIN LV0000100501, Ticker OLF1R) from the Baltic Main List. The last listing day of AS "Olainfarm” is set to January 10, 2022. Additional information:  Jānis LeimanisJSC Olainfarm Member of the Management BoardTel. E-pasts:

 PRESS RELEASE

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta

AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta AS "Olainfarm” akcijas izslēdz no Baltijas Oficiālā saraksta Ar šo AS "Olainfarm” informē, ka Nasdaq Riga š.g. 7. janvārī pieņēma lēmumu apstiprināt AS "Olainfarm” akciju (ISIN LV0000100501, Biržas kods OLF1R) izslēgšanu no Baltijas Oficiālā saraksta, par pēdējo akciju kotācijas dienu nosakot 2022. gada 10. janvāri. Papildu informācija:Jānis LeimanisAS “Olainfarm” valdes loceklisTel. E-pasts:

 PRESS RELEASE

Notification about results of final buy-back of shares

Notification about results of final buy-back of shares Notification about results of final buy-back of shares Target company Joint Stock Company " Olainfarm ", registration number  40003007246, legal address: Rupnicu str. 5, Olaine, LV-2114, Latvia, phone: (+371) 67013705, e-mail:  , website: , hereinafter - Target Company.  Offeror AS “AB CITY”, registration number 40203174414, date and place of registration 11.10.2018., Rīga, legal address: Ganību dambis 24D, Riga, LV-1005, e-mail:  , website: , hereinafter - Offeror. Number of shares offered for sale A total of 549 8...

 PRESS RELEASE

Paziņojums par galīgās akciju atpirkšanas rezultātiem

Paziņojums par galīgās akciju atpirkšanas rezultātiem Paziņojums par galīgās akciju atpirkšanas rezultātiem Mērķa sabiedrība Akciju sabiedrība „Olainfarm”, reģistrācijas numurs 40003007246, juridiskā adrese: Rūpnīcu iela 5, Olaine, Olaines novads, LV-2114, tālr. (+371) 67013705; e-pasts: , mājaslapas adrese: , turpmāk – Mērķa sabiedrība. Piedāvātājs AS “AB CITY”, reģistrācijas numurs 40203174414, reģistrācijas datums un vieta 11.10.2018., Rīga, juridiskā adrese: Ganību dambis 24D, Rīga, LV-1005, e-pasts: , mājaslapas adrese: , turpmāk - Piedāvātājs. Pārdošanai p...

 PRESS RELEASE

Notification about final share buy-back

Notification about final share buy-back Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that by decision No. 185 of 28th December 2021, the Financial and Capital Market Commission allowed AS “AB CITY”, registration number 40203174414, to carry out the Company’s  final share buy-back. Final buy-back price is 9,26 EUR per share. The value of one share has been calculated in accordance with Section 74, Paragraphs one, Clause 3 of the Financial Instruments Market Law. The entry date is the next working day after the date of publishing the informati...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch